HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study

NCT06798246 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Upper Tract Urothelial Carcinoma

Interventions

DRUG: Chemotherapy
DRUG: Immunotherapy
DRUG: ADC
DRUG: Chemotherapy combined with immunotherapy

Sponsor

Peking University First Hospital

Collaborators

[object Object]
[object Object]
[object Object]